CASS Pharmaceuticals, Inc. — Form D
CASS Pharmaceuticals, Inc. of FRANKLIN, TN, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-01. The offering totals $5.0M, of which $150K was reported sold. Industry: Other Technology.
Offering
- Filed: 2020-09-01
- Form: D
- Accession: 0001822787-20-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $150K
- Remaining: $4.8M
- Investors: 1
- Date of first sale: 2020-08-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-374564
Issuer
- Name: CASS Pharmaceuticals, Inc.
- CIK: 0001822787
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1465 WILLOWBROOKE CIRCLE, FRANKLIN, TN, 37069
- Phone: (914) 329-3112
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Solomon Steiner | Director | Danbury, CT |
| Solomon Steiner | Executive Officer | Danbury, CT |
| Solomon Steiner | Promoter | Danbury, CT |
| Stephen McCormack | Director | FRANKLIN, TN |
| Stephen McCormack | Executive Officer | FRANKLIN, TN |
| Stephen McCormack | Promoter | FRANKLIN, TN |
Other filings by this issuer (1)
More